Create an account to save custom article collectionsLog In
  • Categories:
  • Plasma Cell Disorders
  • Non-Hodgkin's Lymphomas
  • Chronic Lymphocytic Leukemia
  • Hodgkin Lymphoma
  • Myelodysplastic neoplasms
  • Acute Leukemia
  • Chronic Myeloid Disorders
  • BMT & CAR-T cell therapy
  • Histiocytic|Dendritic Neoplasms
  • Hemostasis and Thrombosis
  • Mastocytosis
  • AI in Oncology
  • Prognostic model research
  • Sepsis
  • AI in Hematology

2022 © SCI-PUB, Beta version, All Rights reserved

Chronic Lymphocytic Leukemia

Gribben JG. Targeting the methylome to improve CLL outcome. Blood. 2023;142(1):4-6.

No abstract text is available for this article

DOI: 10.1182/blood.2023022123
Blood, 2023-09-22

Interruption of BTK inhibitor improves response to SARS-CoV-2 booster vaccination in patients with CLL.

B-cell targeted therapies, including anti-CD20 monoclonal antibodies (mAb) and Bruton's tyrosine kinase inhibitors (BTKi), further suppress antibody (Ab) response to vaccines in patients with chronic lymphocytic leukemia (CLL)...

DOI: 10.1080/10428194.2023.2258243
Tomasulo E, Paul S, Mu R, Tian X, Chen J, Pleyer C, Wiestner A, Sun C
Leukemia & lymphoma, 2023-09-22
2023 © SCI-PUB, All Rights reserved.
Наверх

Contact Us

All fields are required

Log In

Forgot password?
 
Please, register for full access to SCI-PUB.

Password recovery

Back to Login
 
Please, register for full access to SCI-PUB.